Abstract
Hemophagocytic lymphohistiocytosis (HLH) and Epstein-Barr virus myelitis may manifest with CNS symptoms. Given the similar clinical neurologic presentations of both conditions, differentiating Epstein-Barr virus myelitis from CNS HLH may prove difficult in a patient with a history of HLH. Herein we report a case of Epstein-Barr virus myelitis treated with intrathecal rituximab in a patient with a history of HLH in remission and highlight the role of radiographic imaging in the proper diagnosis.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
